Differential Protein Expression in Response to Varlitinib Treatment in Oral Cancer Cell Line: an In Vitro Therapeutic Approach.

varlitinib (ASLAN001) - ASLAN Pharma

http://www.ncbi.nlm.nih.gov/pubmed/37470935

Aftab Ahmed; Amber Ilyas; Basir Syed; Fariha Tanveer; Shamshad Zarina; Zehra Hashim

Jul 20, 2023